Re : 酶替代疗法在美国 1 型 gaucher 病中的预算影响。
关键词: ERT US payers budget-impact analysis eliglustat velaglucerase alfa
Mesh : Humans United States Gaucher Disease / drug therapy Enzyme Replacement Therapy Drug Administration Schedule Treatment Outcome
来 源: DOI:10.1080/13696998.2023.2197812